Certified by Founder Lodge
Sionna Therapeutics
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $182,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecul
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2024 | Series C | $182,000,000 |
Atlas Venture
Viking Global Investors
RA Capital Management, L.P.
T. Rowe Price
Enavate Sciences
Perceptive Advisors
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
StretchSense | $2,300,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
